Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device, the Fully Implanted Acclaim® Cochlear Implant WHITE BEAR LAKE, Minn., March 31, 2025 (Newsfile Corp.) -- Envoy Medical®, Inc. ("Envoy Medical") (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing devices, today announced its corporate and financial r ...